John T Curnutte
CIK 1574589 · EVP R&D · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
42
Lifetime Open-Market Net
-$7.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLRX | Director | — | $1.07 | — | $0 | 6 | 2026-06-12 |
| Orchard Therapeutics plc (ORTX) Delisted | Director | — | $16.70 | — | $0 | 5 | 2024-01-24 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | EVP R&D | 102,559 | — | — | -$7.83M | 30 | 2019-05-21 |
Recent Filings · Page 2 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-19 | Orchard Therapeutics plc (ORTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-21 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Mixed | +3,117 | -$95.3K | EDGAR |
| 2019-03-05 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Tax (F) | −6,446 | -$215.4K | EDGAR |
| 2019-02-04 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2019-01-15 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Mixed | +1,035 | -$17.3K | EDGAR |
| 2018-09-05 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Mixed | +8,616 | -$259.2K | EDGAR |
| 2018-08-28 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Mixed | +9,329 | -$212.9K | EDGAR |
| 2018-05-24 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Mixed | +3,040 | -$67.2K | EDGAR |
| 2018-03-14 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Exer (M) | +5,049 | $42.9K | EDGAR |
| 2018-03-06 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Tax (F) | −4,530 | -$147.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.